Oscar Health (NYSE:OSCR) Posts Earnings Results, Beats Estimates By $0.70 EPS

Oscar Health (NYSE:OSCR) posted its quarterly earnings results on Thursday. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70, FiscalAI reports. The business had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a return on equity of 44.96% and a net margin of 3.60%.The business’s revenue was up 70.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.89) EPS.

Here are the key takeaways from Oscar Health’s conference call:

• Strong profitability and raised outlook: Oscar reported $1.1 billion in first-half earnings from operations and $1 billion in net income. Management raised full-year earnings-from-operations guidance by $250 million to $500 million–$700 million while maintaining its revenue outlook.
• Membership and operating metrics improved materially: Effectuated membership increased 46% year over year to 2.96 million, revenue rose 70% to $4.9 billion, and second-quarter MLR improved nearly 12 points to 79.2%. The SG&A ratio fell 450 basis points to a record-low 14.2%.
• Favorable medical trends provide potential upside: Inpatient, professional, and pharmacy utilization were favorable, while outpatient utilization was elevated but stable. Early 2026 morbidity data was better than pricing assumptions, although Oscar has not fully reflected that potential benefit in its guidance.
• Technology and AI are driving efficiency: Oscar said its AI-enabled claims, pharmacy, care-navigation, and member-support tools are reducing costs and improving productivity. The company expects its pharmacy analytics and related initiatives to generate tens of millions of dollars in annual savings and sees additional SG&A leverage ahead.
• Enrollment churn is expected to increase in the second half: CMS eligibility and program-integrity reviews are expected to produce disenrollments that were delayed from the second quarter, with churn potentially approaching twice the previously expected 1%–2% monthly rate. Management said the financial impact is included in guidance and primarily reflects timing rather than a fundamental change in retention.

Oscar Health Stock Performance

Shares of Oscar Health stock traded up $1.39 during midday trading on Friday, hitting $27.93. The company had a trading volume of 10,468,402 shares, compared to its average volume of 4,846,594. The company has a fifty day simple moving average of $28.93 and a 200 day simple moving average of $20.37. The stock has a market cap of $8.42 billion, a price-to-earnings ratio of 19.95, a PEG ratio of 1.35 and a beta of 2.36. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health has a 12-month low of $10.69 and a 12-month high of $33.10.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on OSCR shares. Piper Sandler restated an “overweight” rating and issued a $36.00 target price on shares of Oscar Health in a research note on Tuesday, July 28th. Wall Street Zen raised Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Weiss Ratings upgraded Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday, July 10th. Robert W. Baird set a $27.00 price objective on Oscar Health in a research report on Friday. Finally, Wolfe Research assumed coverage on Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $24.00.

Oscar Health News Summary

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Substantial earnings and revenue beat: Oscar reported quarterly EPS of $1.10, versus the $0.40–$0.43 analyst consensus, compared with a $0.89 loss in the year-ago quarter. Revenue rose 70.4% to $4.88 billion, exceeding estimates of approximately $4.73 billion. Oscar Health Inc. Q2 Earnings Beat Estimates
• Positive Sentiment: Profitability improved sharply: The insurer generated approximately $361 million of second-quarter profit and more than $1 billion in net income during the first half, helped by membership growth and easing medical costs. Oscar Health Reports Another Big Profit
• Positive Sentiment: Full-year outlook was raised: Oscar increased its 2026 revenue forecast to $18.7 billion–$19.0 billion, above the roughly $18.6 billion consensus estimate, and indicated $500 million–$700 million in earnings from operations with an 81.5%–82.5% medical-loss-ratio target. Oscar Health Signals 2026 Earnings Outlook
• Neutral Sentiment: The results reinforce Oscar’s improving profit-turnaround story, with technology and operational execution remaining important to managing a changing customer base. Oscar Health 2026 Profit Turnaround
• Negative Sentiment: Churn outlook pressured the shares: Management’s forecast for elevated member churn raised concerns about retention, future enrollment growth and whether the unusually strong earnings can be sustained. That concern reportedly outweighed the quarterly beat and guidance increase. Oscar Health Falls as Churn Forecast Overshadows Q2 Beat

Insider Activity at Oscar Health

In other Oscar Health news, CEO Mark T. Bertolini sold 624,244 shares of the firm’s stock in a transaction on Tuesday, June 30th. The shares were sold at an average price of $28.48, for a total value of $17,778,469.12. Following the completion of the transaction, the chief executive officer owned 7,751,570 shares of the company’s stock, valued at approximately $220,764,713.60. This trade represents a 7.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 880,000 shares of the business’s stock in a transaction on Tuesday, June 23rd. The shares were sold at an average price of $29.38, for a total transaction of $25,854,400.00. Following the sale, the director directly owned 480,866 shares in the company, valued at $14,127,843.08. This trade represents a 64.66% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 3,662,466 shares of company stock worth $105,145,815. 22.64% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Strs Ohio acquired a new stake in shares of Oscar Health during the first quarter worth about $30,000. Jones Financial Companies Lllp raised its position in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after buying an additional 2,242 shares during the last quarter. Quarry LP lifted its stake in Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares during the period. Binnacle Investments Inc acquired a new stake in Oscar Health during the 2nd quarter valued at approximately $75,000. Finally, National Bank of Canada FI purchased a new stake in shares of Oscar Health in the 3rd quarter valued at $81,000. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.